WILMINGTON, Del., Dec. 22, 2014 /PRNewswire/ -- Rigrodsky &
Long, P.A.:
- Do you own shares of Uroplasty, Inc. (NASDAQ CM:
UPI)?
- Did you purchase any of your shares prior to December 22, 2014?
- Do you think the proposed buyout value is too low?
- Do you want to discuss your rights?
Rigrodsky & Long, P.A. announces that it is investigating
potential legal claims against the board of directors of Uroplasty,
Inc. ("Uroplasty" or the "Company") (NASDAQ CM: UPI) regarding
possible breaches of fiduciary duties and other violations of law
related to the Company's entry into an agreement to be acquired by
Vision-Sciences, Inc. ("Vision-Sciences") (NASDAQ CM: VSCI).
Click here to learn more:
http://www.rigrodskylong.com/investigations/uroplasty-inc-upi-buyout.
Under the terms of the agreement, shareholders of Uroplasty will
receive 3.6331 shares of Vision-Sciences common stock for each
share of Uroplasty common stock. Based on Vision-Sciences'
closing stock price on December 19,
2014, Uroplasty shareholders would have received
consideration valued at approximately $3.67 per share.
The investigation concerns whether Uroplasty's board of
directors failed to adequately shop the Company and obtain the best
possible value for Uroplasty's shareholders before entering into an
agreement with Vision-Sciences. According to Yahoo! Finance,
at least one analyst has issued a price target for Uroplasty stock
at $6.00 per share.
If you own the common stock of Uroplasty and purchased your
shares before December 22, 2014, if
you have information or would like to learn more about these
claims, or if you wish to discuss these matters or have any
questions concerning this announcement or your rights or interests
with respect to these matters, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2
Righter Parkway, Suite 120, Wilmington,
DE 19803, by telephone at (888) 969-4242; by e-mail to
info@rl-legal.com, or at:
http://www.rigrodskylong.com/investigations/uroplasty-inc-upi-buyout.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes
securities class, derivative and direct actions, shareholder rights
litigation and corporate governance litigation, on behalf of
shareholders in states and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a
similar outcome.
CONTACT:
Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242
(302) 295-5310
Fax: (302) 654-7530
info@rl-legal.com
http://www.rigrodskylong.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/uroplasty-inc-shareholder-alert-rigrodsky--long-pa-announces-investigation-of-buyout-300013211.html
SOURCE Rigrodsky & Long, P.A.